| scholarly article | Q13442814 |
| P50 | author | James A Underberg | Q37831367 |
| P2093 | author name string | Qing Ma | |
| Judith A Aberg | |||
| Gene D Morse | |||
| Carlos D Malvestutto | |||
| P2860 | cites work | Pitavastatin in cardiometabolic disease: therapeutic profile | Q21246037 |
| Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. | Q34094825 | ||
| Drug-drug interaction between pitavastatin and various drugs via OATP1B1. | Q34566306 | ||
| Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108. | Q34599850 | ||
| The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy. | Q34613443 | ||
| Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors | Q36544977 | ||
| Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans | Q36687277 | ||
| Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs | Q37481450 | ||
| Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors. | Q38109095 | ||
| Statin myotoxicity: a review of genetic susceptibility factors | Q38157284 | ||
| Induction of multiple drug transporters by efavirenz | Q39880991 | ||
| Effects of steady-state lopinavir/ritonavir on the pharmacokinetics of pitavastatin in healthy adult volunteers | Q42649723 | ||
| Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. | Q42671235 | ||
| Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death | Q44200949 | ||
| Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application | Q44208340 | ||
| Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring | Q46121532 | ||
| Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study | Q46568560 | ||
| Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. | Q51859231 | ||
| Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin | Q95423232 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ritonavir | Q422618 |
| efavirenz | Q422645 | ||
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 390-396 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir | |
| P478 | volume | 67 |
| Q41996857 | A review of drug-drug interactions in older HIV-infected patients |
| Q88874091 | Benefits and Risks of Statin Therapy in the HIV-Infected Population |
| Q38881481 | Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes |
| Q40311279 | Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. |
| Q42656331 | Evidence-based review of statin use in patients with HIV on antiretroviral therapy |
| Q40162393 | HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial. |
| Q95925630 | Intestinal P-gp and Putative Hepatic OATP1B Induction: ITC Perspective on Drug Development Implications |
| Q50915503 | Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. |
| Q37038775 | Pathophysiology and management of cardiovascular disease in patients with HIV |
| Q40239735 | Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial |
| Q39212423 | Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications |
| Q36399904 | Statins to improve cardiovascular outcomes in treated HIV infection |
Search more.